No Prescription |
 |
 | ||
|
Flixotide CFC free Inhaler Generic Fluticasone Propionate |
|
| ||
No Prescription » Prescription Drugs 7 » Flixotide CFC free Inhaler Generic Fluticasone Propionate Flixotide puffers contain a medicine called fluticasone propionate. This medicine belongs to a group of medicines known as corticosteroids frequently called 'steroids'. They are not 'anabolic steroids' which are the steroids sometimes misused by athletes.Your Flixotide puffer provides a measured amount of steroid for you to breathe into your lungs. By using your Flixotide puffer regularly every day the medicine reduces the swelling and irritation in the walls of the small air passages in your lungs. Your Flixotide puffer contains the type of asthma medicine known as a 'preventer'. It does not give immediate relief from an asthma attack and may take up to a week to start to work. If your shortness of breath or wheeze does not get better after 7 days tell your doctor. When used every day your Flixotide puffer helps to ease breathing problems and prevent asthma attacks.This medicine is only one part of a general plan to help you manage your asthma. You should discuss this plan with your doctor. You may also be using a 'reliever puffer'. Keep using it according to your doctor's advice. Ask your doctor to check your treatment regularly.Ask your doctor if you have any questions about why a Flixotide puffer has been prescribed for you.The medicine in Flixotide puffers is not addictive.Flixotide puffers generally do not cause any problems with your ability to drive a car or operate machinery. Buy Flixotide CFC free Inhaler Generic Fluticasone Propionate and other Prescription Drugs 7 products online at Medstore. Buy Online at Medstore - Click Here!
About Flixotide CFC free Inhaler Generic Fluticasone Propionate: Product Type: Prescription Drugs 7 Flixotide CFC free Inhaler ( Generic Fluticasone Propionate ) Flixotide CFC free Inhaler (Generic Fluticasone Propionate) Generic Fluticasone Propionate 125mcg per actuation 120 Dose 125mcg per actuation 3 x 120 Dose 250mcg per actuation 120 Dose 250mcg per actuation 3 x 120 Dose 50mcg per actuation 120 Dose 50mcg per actuation 3 x 120 Dose Generic Fluticasone Propionate Flixotide CFC free Inhaler
View more Prescription Drugs 7 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
